To probe the physiological role of calsequestrin in excitation-contraction coupling, transgenic mice overexpressing cardiac calsequestrin were developed. Transgenic mice exhibited 10-fold higher levels of calsequestrin in myocardium and survived into adulthood, but had severe cardiac hypertrophy, with a twofold increase in heart mass and cell size. In whole cell-clamped transgenic myocytes, Ca2+ channel-gated Ca2+ release from the sarcoplasmic reticulum was strongly suppressed, the frequency of occurrence of spontaneous or Ca2+ current-triggered "Ca2+ sparks" was reduced, and the spark perimeter was less defined. In sharp contrast, caffeine-induced Ca2+ transients and the resultant Na+-Ca2+ exchanger currents were increased 10-fold in transgenic myocytes, directly implicating calsequestrin as the source of the contractile-dependent pool of Ca2+. Interestingly, the proteins involved in the Ca2+-release cascade (ryanodine receptor, junctin, and triadin) were downregulated, whereas Ca2+-uptake proteins (Ca2+-ATPase and phospholamban) were unchanged or slightly increased. The parallel increase in the pool of releasable Ca2+ with overexpression of calsequestrin and subsequent impairment of physiological Ca2+ release mechanism show for the first time that calsequestrin is both a storage and a regulatory protein in the cardiac muscle Ca2+-signaling cascade. Cardiac hypertrophy in these mice may provide a novel model to investigate the molecular determinants of heart failure. 
Introduction
In the heart, Ca 2 ϩ signaling is mediated by a sequence of events, starting with ( a ) opening of the L-type Ca /mol of calsequestrin, with K D ϭ 0.4-1 mM at 150 mM KCl) (2) , contains no transmembrane domains, and is located solely within the lumen of the SR (3). Structurally, calsequestrin contains 109 acidic amino acids with an excess of 69 negatively charged residues, contributing, in large part, to its ability to bind a large amount of Ca 2 ϩ (3). Although the physiological role of calsequestrin is poorly understood, its association with terminal cisternae (4), its conformational change upon binding of Ca 2 ϩ (2, 5), and its apparent anchoring to the ryanodine receptor via junctional face proteins such as triadin (6) and junctin (7, 8) suggest that calsequestrin may play a regulatory role in the Ca 2 ϩ -release process (9) (10) (11) (12) .
To examine the physiological role of cardiac calsequestrin, transgenic mice with targeted overexpression of cardiac calsequestrin in atrium and ventricle were produced, and possible alterations in the Ca 2 ϩ -signaling cascade were examined and quantified.
Methods
Generation of calsequestrin-overexpressing transgenic mice. The 1378-bp SmaI restriction enzyme fragment from canine cardiac calsequestrin cDNA clone IC3A (3) was subcloned into pBluescript SK (Stratagene, La Jolla, CA) and then digested with SalI and SacI restriction enzymes. The SalI-SacI fragment, containing the entire canine cardiac calsequestrin protein coding region (including the signal peptide sequence) and 135 bp of 5 Ј -and 10 bp of 3 Ј -untranslated sequences, was ligated into the SalI-SacI sites of a mouse cardiac ␣ -myosin heavy chain ( ␣ -MHC) promoter expression cassette (13) . The expression cassette subcloned into pSPT included the ␣ -MHC promoter and 5 Ј -untranslated region (a 5.7-kb insert described in Scott et al. [3] ) fused to a 0.2-kb fragment containing the SV40 transcriptional terminator. The transgene, composed of the ␣ -MHC promoter, the entire protein coding region for calsequestrin, and the SV40 polyadenylation signal 2 ϩ ] i , intracellular Ca 2 ϩ concentration; I Ca , Ca 2 ϩ current; I Na/Ca , Na ϩ -Ca 2 ϩ exchanger current; ␣ -MHC, ␣ -myosin heavy chain; SR, sarcoplasmic reticulum.
sequence was isolated from the parent plasmid as a 7.4-kb NruI fragment and used for embryo microinjections (14) . Transgene-positive mice were identified by PCR assay of toe digests using primers designed to selectively amplify the transgene (15). Animals (6-9 wk old) were used in accordance with institutional guidelines.
Immunoblotting. Levels of SR proteins were determined by immunoblot analysis. 200 g (for detection of the ryanodine receptor) or 40 g (for detection of other SR proteins) of ventricular homogenate proteins was subjected to 5% (for ryanodine) or 8% (for other proteins) SDS-PAGE, blotted to nitrocellulose, and probed with antibodies specific for calsequestrin, ryanodine receptor, cardiac triadin isoform 1, junctin, Ca 2 ϩ -ATPase, and phospholamban (6, 7, 16) . Blots were developed with 125 I-protein A or alkaline phosphatase-conjugated protein A (for triadin). Immunoreactive bands were quantified by a molecular imager (model GS-250; Bio-Rad Laboratories, Richmond, CA).
Electron microscopy. Hearts from 4-wk-old wild-type and calsequestrin-overexpressing mice were fixed by perfusion through the left ventricle with a Ca 2 ϩ -free Ringer's solution, followed by 3.5% glutaraldehyde in 0.1 M cacodylate buffer. Small parallel bundles of fibers were teased from the walls of the left ventricle, postfixed in 2% OsO 4 in 0.1 M cacodylate buffer, rinsed briefly, enblock stained with saturated uranyl acetate at 60 Њ C for 4 h, and embedded in Epon. Sections were further stained with uranyl acetate and lead solutions and examined in an electron microscope (model EM410; Philips, Eindhoven, The Netherlands) (17) .
[ -release channels in junctional SR vesicles (18, 19) . Oxalate precipitates actively sequestered Ca 2 ϩ retained inside SR vesicles, giving a 1,000-fold increase in uptake rates and negating any contribution by calsequestrin (18, 19) .
Cardiac myocyte isolation. Ventricular myocytes were isolated from mice using the collagenase/protease method (20) that is a modification of the original method of Mitra and Morad (21) . Briefly, animals were anesthetized with sodium pentobarbital (50 mg/kg, intraperitoneal). Hearts were excised and perfused, at 1.2 ml/min in a Langendorff apparatus, first with Ca 2 ϩ -free Tyrode solution composed of (in mM) 137 NaCl, 5. ] i ) was calculated (23) . Since rapid application of caffeine causes intracellular Ca 2ϩ release and activates inward Na ϩ -Ca 2ϩ exchanger current (I Na/Ca ) (24), caffeine-induced SR Ca 2ϩ release and I Na/Ca were monitored simultaneously at Ϫ90 mV. Cells were exposed to 5 mM caffeine for 1.8 s using a rapid concentration clamp system (22) . The transient inward current (I Na/Ca ) generated by caffeine-induced Ca 2ϩ release represents exchange of three Na ϩ for one Ca 2ϩ .
Confocal imaging.
Ca 2ϩ currents and two-dimensional Ca 2ϩ images were monitored simultaneously in myocytes dialyzed with internal solutions containing fluo-3 (Molecular Probes, Inc.). Fluorescence images were recorded using an acoustooptically steered confocal microscope (Noran Instruments, Milton Keynes, UK) at 120 frames/s with a pixel size of 0.207 m and 3 ϫ 3 filtering before plotting on a common color scale.
Statistical analysis. MeansϮSEM were calculated, and statistically significant differences between two groups were determined by the Student's t test at P Ͻ 0.05.
Results

Overexpression of calsequestrin alters gene expression of Ca
2ϩ
regulatory proteins and causes cardiac hypertrophy. The level of the expression of calsequestrin in transgenic hearts was 10-fold higher than in control mice as quantified by Western blot analysis ( Fig. 1) . Remarkably, other proteins of the junctional SR, the ryanodine receptor, triadin, and junctin were downregulated by 50% or more, whereas the levels of proteins associated with active sequestration of Ca into adulthood, develop cardiac hypertrophy (1.9-fold increase in mass compared with their nontransgenic littermates; Table  I ) with focal areas of fibrosis, accompanied by rapid heart rate, increased respiratory rate, and fluid retention. Enzymatically isolated ventricular myocytes (19) from calsequestrin-overexpressing mice were significantly larger ‫ف(‬ 240 vs. 151 pF; Table  I ), and had a distinctive appearance with blurred striations (Fig. 2) .
Ultrastructural analysis demonstrates that myocytes from hearts expressing excessive amounts of calsequestrin are filled with a large number of membrane-limited vesicles which pervade the entire cell outline (Fig. 3 A, arrows) , displacing myofibrils and mitochondria. The vesicles contain a fine-grained electron-dense network (Fig. 3 B) , presumably consisting of calsequestrin. The fine-grained appearance of calsequestrin within the vesicles is typical of that observed in the center of the terminal SR vesicles in skeletal muscle (17) , but differs from the more clustered disposition of calsequestrin in the proximity of the feet-bearing domain of the SR membrane in skeletal and cardiac muscle.
Junctions between the SR and the surface membrane, or peripheral couplings (Fig. 3 C) , and between the SR and T tubules (Fig. 3 D) are less frequent than in wild-type myocardium and have two distinguishing features (compare Fig. 3 , C and D, with E). First, the junctions are smaller, due to the fact that the surface area of apposed membranes is smaller, and fewer feet (arrows) are present. Second, the junctional SR in the wild-type myocardium (Fig. 3 E) has the characteristic flattened shape and a dense periodically disposed content (25, 26) identified with calsequestrin. In the overexpressing myocardium, on the other hand, the junctional SR is enlarged, and the calsequestrin content is more dispersed (Fig. 3, C and D) .
To assess the functional contribution of ryanodine receptors in transgenic myocytes, radioactive 45 Ca 2ϩ uptake by SR vesicles in whole heart homogenates was measured in the presence and absence of 300 M ryanodine. Ca 2ϩ uptake in the absence of ryanodine reflects Ca 2ϩ transport by the longitudinal SR vesicles and the fraction of junctional SR vesicles with closed release channels. On the other hand, Ca 2ϩ uptake stimulated by ryanodine reflects the fraction of junctional SR vesicles with open Ca 2ϩ release channels, which are closed upon addition of ryanodine to the assay medium (18, 19) . Fig. 4 shows that Ca 2ϩ uptake stimulated by ryanodine decreased greatly in calsequestrin-overexpressing compared with control heart homogenates. This finding is consistent with the observed downregulation of the proteins involved in the Ca 2ϩ -release cascade (ryanodine receptor, triadin, and junctin; Fig. 1 and Table I) , and strongly suggests the functional impairment of Ca 2ϩ -release apparatus in transgenic hearts overexpressing calsequestrin. We observed consistently a higher level (10-25% increase) of total Ca 2ϩ uptake in homogenates from transgenic mice, which could reflect the slightly increased content of Ca 2ϩ pumps (Fig. 1) or the expanded SR volume (Fig.  3 ) in these animals.
Caffeine-induced Ca 2ϩ release is enhanced by calsequestrin overexpression. In enzymatically isolated ventricular myocytes (21) from calsequestrin-overexpressing transgenic mice, strikingly large caffeine-induced Ca 2ϩ releases could be triggered (Fig. 5) , which often saturated the Ca 2ϩ indicator dye (0.1 mM fura-2), suggesting that large Ca 2ϩ concentrations were available in the diadic junctions for release. In the vast majority of myocytes, the impressively larger caffeine-induced Ca 2ϩ release damaged irreversibly the myocytes. Nevertheless, before loss of giga-seal, large and rapidly activating I Na/Ca levels were 151Ϯ6 (n ϭ 23) 240Ϯ12 (n ϭ 54)* Calcium current, I Ca (pA/pF) (0.1 mM fura-2) 11.6Ϯ1.1 (n ϭ 3) 7.8Ϯ0.9 (n ϭ 8) (2 mM fura-2) 7.1Ϯ3.2 (n ϭ 4) 7.3Ϯ2.0 (n ϭ 6) (1 mM fluo-3, 1 mM EGTA) 9.8Ϯ1.8 (n ϭ 5) 11.4Ϯ1.9 (n ϭ 5) (1 mM fluo-3, 14 mM EGTA) 11.3Ϯ2.1 (n ϭ (Fig. 5 A) . In calsequestrin-overexpressing myocytes dialyzed with 0.1 mM fura-2, the caffeine-induced intracellular Ca 2ϩ transients (Ca i -transients), though significantly underestimated because of saturation of the dye, were 2.1Ϯ0.3 M (SEM, n ϭ 9) activating peak I Na/Ca of 6.1Ϯ0.8 pA/pF (SEM, n ϭ 11). In control myocytes, caffeine-induced Ca i -transients averaged only 0.9Ϯ0.3 M activating peak I Na/Ca of 1.5Ϯ0.2 pA/pF. Thus, I Na/Ca levels in calsequestrin-overexpressing myocytes were not only much larger than in controls but also than those of transgenic mice overexpressing the cardiac Na ϩ -Ca 2ϩ exchanger ‫ف(‬ 5 pA/pF) (20) . In addition to the significantly larger (two-to fourfold) peak values of ⌬ [Ca 2ϩ ] i and I Na/Ca in transgenic myocytes, it was apparent that both Ca i -transients and I Na/Ca remained at much higher levels above baseline values after the exposure of myocytes to caffeine, suggesting a much larger increase in total Ca 2ϩ released as well as Ca 2ϩ transported via the Na ϩ -Ca 2ϩ exchanger in transgenic myocytes. In fact, integration of the areas under the curves in Fig.  3 A showed that the total caffeine-induced Ca 2ϩ release was increased by ‫ف‬ 10-fold in the calsequestrin-overexpressing mice, consistent with the 10-fold increase in the level of overexpression of the protein (Fig. 1) . Surprisingly, large densities of I Na/Ca continued to be activated in transgenic myocytes (n ϭ 14) even when myocytes were dialyzed with 2 mM fura-2 ( Fig.  5 B) . These findings suggest that in calsequestrin-overexpressing transgenic myocytes, [Ca 2ϩ ] i in the microdomain surrounding the Na ϩ -Ca 2ϩ exchanger may rise to a sufficiently high level to withstand the strong Ca 2ϩ buffering imposed by fura-2. The ability of calsequestrin-overexpressing myocytes to generate large I Na/Ca when dialyzed with high concentrations of fura-2 was in sharp contrast not only to the control myocytes but also to those obtained from the Na ϩ -Ca 2ϩ exchanger-overexpressing myocytes (20) , underscoring the possibility that Ca 2ϩ concentrations reaching the microenvironment of the Na ϩ -Ca 2ϩ exchanger in calsequestrin-overexpressing myocytes were significantly larger than those estimated from the cytosolic fura-2 fluorescence signals. These are the first data that not only directly implicate calsequestrin as the store of the contractile- (Fig. 6 ). Depending in part on various Ca 2ϩ -buffering conditions, Ca i -transients were two to six times smaller in transgenic compared with control myocytes (Table I ). The ratio of I Ca - induced Ca 2ϩ release to caffeine-triggered Ca 2ϩ release was 0.02 in calsequestrin-overexpressing myocytes compared with 0.47 in control myocytes, suggesting an ‫ف‬ 20-fold decrease in the efficiency of I Ca -gated Ca 2ϩ release in calsequestrin myocytes.
The inability of the Ca 2ϩ channel to trigger effectively the intracellular pools was also apparent from the marked decrease in the inactivation kinetics of I Ca (Fig. 6) . The time constant of inactivation of I Ca was two to four times greater in transgenic compared with control myocytes (irrespective of concentrations of Ca 2ϩ buffers used), even though the amplitude of I Ca did not change significantly (Table I) . It has been suggested previously that the kinetics of inactivation of the Ca 2ϩ channel can serve as a good barometer of Ca 2ϩ content of the SR. Consistent with this idea, marked decreases in the kinetics of inactivation of I Ca were observed in control myocytes when the SR pools were Ca 2ϩ -depleted either by caffeine or thapsigargin (23, 27) , a finding attributed to suppression of Ca 2ϩ cross-signaling between the Ca 2ϩ channel and the ryanodine receptor. In transgenic myocytes with overloaded Ca 2ϩ stores (Fig. 5) , the absence of Ca 2ϩ -induced inactivation of the Ca 2ϩ channel (Fig. 6 ) not only supports the impairment of the release mechanism, but also underscores the idea that the two receptors indeed function as a complex (23, 27) .
The efficacy of the Ca 2ϩ -release complex was further examined using rapid (240 frames/s) scanning laser confocal imaging (Fig. 7) . To limit the diffusion of Ca 2ϩ to ‫ف‬ 50 nm, myocytes were dialyzed with 1 mM fluo-3 and 5 mM EGTA, which enhanced the off-kinetics of the dye and increased the spatial and temporal resolution of confocal images. Spontaneous or I Cainduced focal releases of Ca 2ϩ (Ca 2ϩ sparks) (28) were observed at the holding potential of Ϫ70 mV and when I Ca was activated minimally at Ϫ40 or ϩ60 mV. In resting myocytes, spontaneous focal Ca 2ϩ releases (0.5 m in diameter and 10 ms in duration) were seen in 16 of 18 control myocytes, but were completely absent in 19 of 20 transgenic myocytes examined (compare Fig. 7, A and B) . Full activation of I Ca at 0 mV in control ventricular myocytes produced a highly regular and dynamic pattern of Ca 2ϩ stripes lasting 20 ms (C and E), yielding slowly to a more homogenous rise in cytosolic Ca 2ϩ . The Ca 2ϩ distribution at 0 mV appeared as ridges or beads spaced in register with 2-m sarcomere spacing (Ca 2ϩ stripes). On the other hand, in transgenic myocytes, intracellular Ca 2ϩ signals developed more slowly (F) and appeared after 25 ms (three frames) as a blotchy pattern (D) similar to somewhat smeared large focal releases, but failed to produce the regular and distinct pattern of Ca 2ϩ stripes. It should be noted that the inactivation of I Ca was strongly slowed (Fig. 7 F) , in agreement with the findings of Fig. 6 . In transgenic myocytes, confocal imaging data show that focal Ca 2ϩ releases are initiated infrequently and with slower kinetics and different spatial distribution patterns, resulting in slowly developing and attenuated Ca i -transients (Figs. 6 and 7) suggestive of impairment of the Ca 2ϩ release complex.
Discussion
Although the existence of calsequestrin has been known for over 25 years (29) , knowledge of its physiological roles has been limited to the postulation that it may play an active role in excitation-contraction coupling based on several in vitro studies (9) (10) (11) (12) . The development of transgenic mouse overexpressing cardiac calsequestrin allowed, for the first time, the probing of the role of calsequestrin at the cellular level and showing that this protein is closely and functionally linked to the Ca 2ϩ -release process. Since caffeine-induced Ca 2ϩ release (Figs. 6 and 7) . For instance, the downregulation of triadin (Fig. 1) , postulated as a linking protein in the functional organization of the dihydropyridine-ryanodine receptor complex (32) , is consistent with such a possibility. However, this cannot alone explain the observed failure of the I Ca -induced Ca 2ϩ release mechanism, because in transgenic myocytes bathed continuously in 5 mM caffeine or exposed to isoproterenol, a partial restoration of I Ca -induced Ca 2ϩ release could be observed (our unpublished observation). Therefore, the Ca 2ϩ load of the SR may in itself serve as a determining factor in the negative feedback regulation of the Ca 2ϩ -induced Ca 2ϩ -release mechanism. Such a possibility is supported by recent findings that the ryanodine receptor activity may be inactivated by high luminal Ca 2ϩ concentrations (33, 34). Impairment of I Ca -induced Ca 2ϩ release may in part result from the distortion and/or decrease in the number of diadic junctions (Fig. 3) . It should be noted that impairment of Ca 2ϩ channelgated Ca 2ϩ release in the transgenic myocytes is not accompanied by compensatory activation of Ca 2ϩ release by the exchanger at ϩ10 to ϩ40 mV, even though the exchanger functions very effectively to extrude Ca 2ϩ when faced with a large increase in [Ca 2ϩ ] i (Fig. 5) . Therefore, the large magnitudes of caffeine-induced I Na/Ca in calsequestrin-overexpressing myocytes must be secondary to the large caffeine-triggered Ca 2ϩ releases, rather than compensatory overexpression of the exchanger.
Irrespective of an exact molecular mechanism responsible for impairment of I Ca -induced Ca 2ϩ release, the overexpression of calsequestrin appears to modulate the Ca 2ϩ load of the SR and its physiological release mechanism, suggestive of a dynamic role for calsequestrin in cellular Ca 2ϩ cycling. Our data further suggest that the twofold cardiac hypertrophy (Table I) is likely to result from a significant increase in the size of individual cardiac myocytes (Fig. 2) . The marked increase in the number of the calsequestrin-containing vesicles (Fig. 2) , though it may contribute to the increased heart weight and its structural deformity (Fig. 3) , is unlikely to change the cellular capacitance, because the vesicles are confined to the intracellular space, with little or no sarcolemmal connections. However, it is possible that the observed increase in myocyte size results in part from the unique adaptive response to overexpression of calsequestrin rather than from an increase in myofibrillar mass. Whether the cytosolic calsequestrin-containing vesicles have limited access to Ca 2ϩ -release pools also remains to be determined. However, it should be noted that such pools appear to be unresponsive only to the Ca 2ϩ current (Figs. 6 and 7) and not to the application of caffeine (Fig. 4) , even though both stimuli are known to have a shared site of action on the ryanodine receptor. This finding is therefore more consistent with a defect in dihydropyridine/ryanodine receptor signaling resulting either from altered cytoskeletal spacing that surrounds the cellular microdomains of the Ca 2ϩ -release complex or from a change in the sensitivity of the Ca 2ϩ regulatory site on the ryanodine receptor.
